Autoinjector
Latest Eli Lilly and Company Patents:
- MODIFIED OLIGONUCLEOTIDES
- Oxyntomodulin binding molecules, and uses thereof
- Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol
- Cocrystalline forms of FGFR3 inhibitors
- Drug container systems including lock-out mechanisms
Contrast in surface appearance is shown by line and stipple shading. The broken lines of even length illustrate portions of the mechanism, inner core, and delivery system of the autoinjector and form no part of the claimed design.
Claims
The ornamental design for an autoinjector, as shown and described.
| D739011 | September 15, 2015 | Morrison, Jr. |
| D773650 | December 6, 2016 | Fourt |
| D814022 | March 27, 2018 | Boyaval |
| 10265476 | April 23, 2019 | Laiosa |
| D851754 | June 18, 2019 | Boyaval |
| D870270 | December 17, 2019 | Burkett |
| D878560 | March 17, 2020 | Boyaval |
| D882071 | April 21, 2020 | Stonecipher |
| RE48006 | May 26, 2020 | Fourt |
| D883475 | May 5, 2020 | Boyaval |
| D898189 | October 6, 2020 | Boyaval |
| D898900 | October 13, 2020 | Atterbury |
| 20190328485 | October 31, 2019 | Bauss |
Type: Grant
Filed: Jul 12, 2019
Date of Patent: Aug 3, 2021
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventors: Delroy George Dennisur (Smyrna, GA), Hemant Thakorbhai Patel (Indianapolis, IN), Amin Sedighiamiri (Carmel, IN), Parker Eugene Trow (Indianapolis, IN), Hsuan Tsun Wang (Atlanta, GA)
Primary Examiner: David G Muller
Application Number: 29/697,934